Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Background A significant increased risk of complications and mortality in
immunocompromised patients affected by COVID-19 has been described. However, the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

Knowledge on the immunogenicity of vector-based and mRNA-vaccines in solid organ
transplant recipients is limited. Therefore, SARS-CoV-2–specific T cells and antibodies were …

Transplantation of solid organs from donors with active SARS-CoV-2 infection has been
advised against due to the possibility of disease transmission to the recipient. However, with …

Limited data exists on the effectiveness of a third COVID-19 vaccine dose in solid organ
transplant recipients. We conducted a population-based cohort study using linked …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination may fail
to sufficiently protect transplant recipients against coronavirus disease 2019 (COVID-19) …

Background The effect of solid organ transplantation (SOT) on the severity and mortality of
coronavirus disease 2019 (COVID-19) remained controversial. There is still no consensus …

Abstract Purpose of Review As the prevalence of individuals with recovered coronavirus
disease 2019 (COVID-19) increases, determining if and when organs from these donors can …

In response to the COVID‐19 pandemic, SARS‐CoV‐2 vaccines have been developed at an
unparalleled speed, with 14 SARS‐CoV‐2 vaccines currently authorized. Solid‐organ …